|

Newport Fertility Center
(949)
222-1290
|
|
|
|
 |
 |
 |
 |
|
Embryo Transfer Success |
 |
|
PGD for BRCA |
 |
|
Fertility and Cancer |
 |
|
Ovarian Transplantation |
 |
|
IVF |
| |
|
|
|
Fertility Basics
(From PregnancyandBaby.com)
Facing infertility can be a difficult and emotional time for many
couples. It is normal to have feelings of guilt, anger or sadness
during these trying times. Fortunately, there is a happy ending for
many couples going through this challenge.
Fertility specialist Mark
Kan, MD, explains.
A difficult time
Today, more couples are able to become pregnant than ever before.
Advances in reproductive science and technology have given new hope
to couples who were previously unable to conceive.
Infertility affects 15 percent of couples in the United States. The
average time to conception in young, healthy couples is roughly five
months. Infertility is defined as the inability to conceive after
one year of unprotected intercourse. Approximately 5 million
American couples are affected, with 1.3 million of those receiving
medical advice or treatment per year.
How natural conception occurs
For natural conception to occur, the sperm must fertilize the egg (oocyte),
and the resulting embryo must implant into the lining of the uterus.
The process of fertilization normally takes place in the fallopian
tube, and the fertilized oocyte travels slowly down the length of
the tube over several days before resting in the uterus and
implanting in the endometrial lining. Once implanted, the embryo
continues to develop and grow. Any condition that affects this
natural process can lead to difficulty in conception and pregnancy.
Problems leading to infertility
If a woman does not release an egg regularly (normally once a
month), she is said to have an ovulation disorder (or ovulatory
dysfunction). If there is scarring or blockage of the fallopian
tubes, it may not be possible for the sperm to meet the egg. This is
considered an anatomical problem and can occur from a prior pelvic
infection or endometriosis, among other conditions. These are common
reasons for female infertility, however there can be many reasons a
couple can have a difficult time achieving pregnancy.
Infertility is not only a female condition. Male-factor infertility
is associated with 30 percent to 40 percent of infertile couples.
Some men may have low or abnormal sperm counts which preclude normal
fertilization.
One of the sentinel advances in the treatment of male-factor
infertility was the development of intracytoplasmic sperm injection
(ICSI). Originally pioneered in Belgium by Dr Gianpiero Palermo,
ICSI involves the injection of a single sperm cell directly into the
oocyte. Using this technique, men with extremely poor sperm quality
can father pregnancies using in-vitro fertilization (IVF).
In-vitro fertilization
With the advent of IVF, infertility patients are able to bypass the
tubal fertilization process. IVF is a procedure that involves
ovarian stimulation with medications over a one to two week period
with subsequent egg retrieval. The medication is given to produce
the development of multiple follicles (follicles are structures that
contain eggs).
After multiple eggs are retrieved, they are inseminated and the
resulting embryos are cultured for three to five days in the
laboratory (hence the term "in vitro" fertilization, which is Latin
for "outside the living body").
The last step in the process involves the transfer of the developing
embryos to the mother’s uterus with a thin flexible catheter. Two
weeks after fertilization, pregnancy can be documented using a blood
test.
Who should see a fertility specialist?
There are many reasons couples seek the advice and treatment of
fertility specialists. The most common reason is that couples have
tried on their own after an extended period of time (generally one
year) and are not able to conceive. Some couples are able to
repeatedly become pregnant but are unable to maintain the pregnancy
(a condition called recurrent pregnancy loss). For others, there is
a diagnosed medical condition where only IVF or ICSI can facilitate
pregnancy (for example in severe male-factor patients with low sperm
counts, or in women who do not have fallopian tubes due to previous
surgery).
Treatment is available
Some patients have genetic predispositions, which can be diagnosed
in the embryo before transfer to the uterus (preimplantation genetic
diagnosis), thus decreasing the chance of the baby being affected
with a disease such as Tay-Sachs or Cystic Fibrosis.
Still others may have decreased ovarian reserve due to advancing age
or premature ovarian failure. Despite the causes, there are many
treatment options for patients dealing with these difficult
problems. In addition to fertility concerns, Reproductive
Endocrinologists also diagnose and treat patients with endocrine
disorders like polycystic ovarian syndrome (PCOS) or precocious
puberty. Currently, the training regimen for a Reproductive
Endocrinology and Infertility specialist entails three years of
sub-specialty fellowship preceded by four years of residency in
Obstetrics and Gynecology.
Remarkable achievements have been made in the field of infertility
since the first IVF baby was born in 1978. Assisted reproductive
techniques and advances in related scientific areas have given many
infertile couples the ability to achieve pregnancy and start a
family. Although it can be a challenging time for many of these
couples, there are more options for successful treatment today than
there have ever been in the past.

Research
Development of
a Neural Network to Predict Low Total Motile Count in Sperm
Preparations Using Computer Assisted Semen Analysis Data.
MT Kan, C O’Malley, D Moffit. Samaritan Institute of
Reproductive Medicine, Phoenix, Arizona. Oral Presentation at 54th
annual meeting of the American Society for Reproductive Medicine
10/6/9
A Model for
Preimplantation Genetic Diagnosis (PGD) of the BRCA Tumor Suppressor
Gene- Familial Breast and Ovarian Cancer Prevention Using In-Vitro
Fertilization (IVF) Technology (Prize Presentation, ASRM 2000).
1MT Kan, 1K Xu, 1ZM Shi, 2K Nafa, 1Z
Rosenwaks. 1The Center for Reproductive Medicine and Infertility,
Weill Medical College of Cornell University, New York, NY.
2Department of Human Genetics- Memorial Sloan-Kettering Cancer
Center, New York, NY. 56th Annual Meeting of the American Society
for Reproductive Medicine 10/21/00.
Fertilization, Implantation, and Pregnancy Rates with Recombinant
Follicle Stimulating Hormone (rFSH) versus rFSH Combined with Human
Menopausal Gonadotropins (HMG) in Women Over Forty undergoing In
Vitro Fertilization (IVF). MT Kan,
L Burmeister, OK Davis Z Rosenwaks. The Center for Reproductive
Medicine and Infertility, Weill Medical College of Cornell
University, New York, NY. 56th Annual Meeting of the
American Society for Reproductive Medicine 10/21/00.
Y-bearing
Enrichment of Human Spermatozoa by Hyperosmotic Centrifugation with
Gel Trapping.
MT Kan,
JJ Hariprashad, A Akerman, Z Rosenwaks, GD Palermo. The Center for
Reproductive Medicine and Infertility, Weill Medical College of
Cornell University, New York, NY. 56th Annual Meeting of
the American Society for Reproductive Medicine 10/21/00.
Oocyte
Recovery from an Autologous Ovarian Transplant in the Forearm.
K
Oktay, MT Kan, L Veeck, Z Rosenwaks.
The Center
for Reproductive Medicine and Infertility, Weill Medical College of
Cornell University, New York, NY. Society of Gynecological
Investigators annual meeting, 2001
Effective Cell Sorting after Flow Cytometric Sperm
Sample Analysis in an Azoospermic Patient with Polycystic Kidney
Disease.
A Akerman, M Goldstein, JJ Hariprashad, MT Kan, Z Rosenwaks,
GD Palermo. The Center for Reproductive Medicine and Infertility,
Weill Medical College of Cornell University, New York, NY. 56th
Annual Meeting of the American Society for Reproductive Medicine
10/21/00.
Y-Microdeletions in the Single Spermatozoon.
N
Takeshita, T Takeuchi, MT Kan, A Chiu, Z Rosenwaks, GD
Palermo. The Center for Reproductive Medicine and Infertility,
Weill Medical College of Cornell University, New York, NY. 56th
Annual Meeting of the American Society for Reproductive Medicine
10/21/00.
Current
Options for Fertility Preservation in Patients Undergoing Treatment
for Malignancy. American Society of Clinical Oncology.
Mark T. Kan, M.D., Kutluk Oktay, M.D., Marc
Goldstein M.D., Zev Rosenwaks, M.D. . Manuscript for Annual Meeting
2001.
Recent progress
in oocyte and ovarian tissue cryopreservation and transplantation.Oktay
K, Kan MT, Rosenwaks Z., Curr Opin Obstet Gynecol 2001
Jun;13(3):263-8
Endocrine Function and Oocyte Retrieval After
Autologous Transplantation of Ovarian Cortical Strips to the
Forearm.Oktay K, Economos K, Kan M,
Rucinski J, Veeck L, Rosenwaks Z. JAMA 2001 Sep
26;286(12):1490-1493.
"Transvaginal Ultrasound Guided Embryo Transfer” -
Prize Video Presentation. Mark T. Kan et al. 58th Annual Meeting
of the American Society of Reproductive Medicine, Seattle, WA.
October 2002.

| Our mission is to give the
best possible personalized care to each and every patient.
Please feel free to contact us
to explore your fertility options and learn how we can help
you. |
Dr. Kan |
Fertility Treatment |
In-Vitro Fertilization
|
Reproductive Surgery |
New Patients |
About Us |
Directions
Home |
FAQs |
Testimonials |
Location |
Contact Us |
Home
Copyright © 2005. Newport Fertility Center. All Rights Reserved
20072 S.W. Birch Street, Suite 230
Newport Beach, CA 92660 (949) 222-1290
|